Home › Prostate Cancer › Arizona
Prostate Cancer clinical trials in Arizona
42 studies for Prostate Cancer are looking for participants at sites in Arizona.
Cities in Arizona
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Mayo Clinic Hospital in Arizona, Phoenix
- Mayo Clinic in Arizona, Scottsdale
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT03866382Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- Mayo Clinic, Scottsdale
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 29, 2026 · NCT01492972DESTINY-PANTUMOUR04
- Research Site, Bullhead City
- Research Site, Casa Grande
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- The University of Arizona Cancer Center - North Campus ( Site 0073), Tucson
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06136650This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers, Chandler
- Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers, Gilbert
- Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers, Glendale
- and 5 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 24, 2026 · NCT07028853Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
- Mayo Clinic in Arizona, Scottsdale
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 23, 2026 · NCT07025369A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- City of Hope Cancer Center Phoenix, Goodyear
- University of Arizona Cancer Center, Tucson
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 22, 2026 · NCT07213674Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Honor Health Research Institute, Scottsdale
RecruitingPhase 2/3
Ages 18 to 100 · Men · Updated Sep 22, 2026 · NCT06780670A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
- GSK Investigational Site, Phoenix
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Sep 18, 2026 · NCT06990880A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Phoenix
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 18, 2026 · NCT06952803A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Mayo Clinic in Arizona - Phoenix ( Site 0044), Phoenix
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT06925737A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
- Academic Urology and Urogynecology of Arizona, Peoria
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 15, 2026 · NCT07332000Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Mayo Clinic, Scottsdale
Recruiting
Ages 18 and older · Men · Updated Sep 14, 2026 · NCT06511141Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Mayo Clinic- Phoenix, Phoenix
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 11, 2026 · NCT06056830A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
- HonorHealth, Scottsdale
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 8, 2026 · NCT05800665A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
- Honor Health Research Institute, Scottsdale
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Sep 4, 2026 · NCT07567846Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Banner University Medical Center - Tucson, Tucson
- University of Arizona Cancer Center-North Campus, Tucson
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 2, 2026 · NCT06931340Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Kingman Regional Medical Center, Kingman
- Cancer Center at Saint Joseph's, Phoenix
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Sep 2, 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Banner University Medical Center - Tucson, Tucson
- University of Arizona Cancer Center-North Campus, Tucson
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06632977AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Phoenix
RecruitingPhase 3
Ages 18 and older · Men · Updated Aug 26, 2026 · NCT07611110Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Cancer Center at Saint Joseph's, Phoenix
RecruitingPhase 3
Ages 18 and older · Men · Updated Aug 19, 2026 · NCT04423211A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Western Regional Medical Center - City of Hope Phoenix Goodyear, Goodyear
- HonorHealth Research Institute, Scottsdale
- The University of Arizona Cancer Center - North Campus, Tucson
RecruitingPhase 2
Ages 18 and older · Men · Updated Aug 17, 2026 · NCT06842498FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Mayo Clinic, Phoenix
- Honor Health, Scottsdale
- Arizona Cancer Center at University of Arizona, Tucson
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05919264Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Mayo Clinic, Phoenix
RecruitingPhase 1
Ages 18 to 100 · Men · Updated Aug 13, 2026 · NCT05519449Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
- Investigative Site #108, Goodyear
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT06545942PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
- Banner MD Anderson, Gilbert
RecruitingPhase 3
Ages 18 and older · Men · Updated Jul 22, 2026 · NCT06274047Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
- Mayo Clinic in Arizona, Phoenix
RecruitingPhase 2
Ages 18 and older · Men · Updated Jul 20, 2026 · NCT06378866Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Cancer Center at Saint Joseph's, Phoenix
RecruitingPhase 3
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT06592924Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer
- Mayo Clinic in Arizona, Scottsdale
RecruitingPhase 3
Ages 18 and older · Men · Updated Jun 18, 2026 · NCT06625034Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients
- Mayo Clinic in Arizona, Scottsdale
RecruitingEarly phase 1
Ages 18 and older · Men · Updated Jun 8, 2026 · NCT05045066A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
- Honor Health, Scottsdale
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Jun 4, 2026 · NCT06609005Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Mayo Clinic Arizona, Scottsdale
RecruitingPhase 4
Ages 18 to 100 · Men · Updated Jun 4, 2026 · NCT05803941A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Mayo Clinic, Phoenix
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Mar 27, 2026 · NCT06395519Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy
- Arizona Urology Specialists, Tucson
RecruitingPhase 1
Ages 18 and older · Men · Updated Feb 19, 2026 · NCT06450106A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- HonorHealth Research Institute, Scottsdale
- The University of Arizona Cancer Center, Tucson
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT06778863Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
- Cancer Center at Saint Joseph's, Phoenix
RecruitingPhase 2
Ages 18 and older · Men · Updated Jan 29, 2026 · NCT05806515Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Scottsdale Medical Imaging, LLC, Scottsdale
RecruitingPhase 4
Ages 18 to 64 · All sexes · Updated Jan 22, 2026 · NCT043735644-aminopyridine Treatment for Nerve Injury
- University of Arizona, Tucson
RecruitingPhase 2/3
Ages 45 to 75 · Men · Updated Dec 17, 2025 · NCT03701581A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 111, Tucson
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 21, 2025 · NCT05914116Understanding of Genetics by Men at Risk for Prostate Cancer
- Mayo Clinic, Phoenix
RecruitingHealthy volunteers welcome
Ages 40 to 95 · Men · Updated Nov 6, 2025 · NCT04550845From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.